Introduction and aims The incidence of paediatric inflammatory bowel disease has
increased in recent decades. The aim of the present study was to evaluate the role of …

Crohn's disease is associated with a high economic burden to society due to healthcare
costs and productivity losses, of which, before the introduction of antitumor necrosis factor …

Background: Anti-tumor necrosis factor-alpha and anti-integrin monoclonal antibodies show
great benefits for inducing and maintaining remission, healing the mucosa and restoring the …

Background Therapeutic drug monitoring (TDM) is increasingly performed to optimize
biologic therapy in inflammatory bowel disease (IBD). However, patients and physicians …

The effect of early trough level of infliximab on subsequent... : Medicine The effect of early trough
level of infliximab on subsequent disease course in patients with Crohn disease: A prospective …

Abstract Treatment of inflammatory bowel diseases and rheumatic disorders with anti-tumor
necrosis factor alpha (TNFα) drugs is expensive, while a significant proportion of patients …

Inflammatory bowel disease [IBD] consists of chronic conditions that carry a large economic
burden worldwide. This economic burden has many drivers, including the cost and …

Crohn's disease (CD) is an immune-mediated inflammatory bowel disease, in which
inflammation is driven by a complex interaction between the microbiota, immune cells …

Introducción y objetivos La incidencia de la enfermedad inflamatoria intestinal pediátrica ha
aumentado en las últimas décadas. El objetivo del presente estudio fue evaluar el papel de …

Introduction: Crohn's disease (CD) is a manifestation of inflammatory bowel disease (IBD),
which can result in significant morbidity. Biologic therapy with anti-TNF medication has been …